Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Chubb
Cantor Fitzgerald
Mallinckrodt
Moodys
AstraZeneca
Express Scripts
Queensland Health
Accenture
Harvard Business School

Generated: January 21, 2018

DrugPatentWatch Database Preview

ERYTHROMYCIN LACTOBIONATE Drug Profile

« Back to Dashboard

When do Erythromycin Lactobionate patents expire, and when can generic versions of Erythromycin Lactobionate launch?

Erythromycin Lactobionate is a drug marketed by Abraxis Pharm, Baxter Hlthcare, and Teva Parenteral. and is included in three NDAs.

The generic ingredient in ERYTHROMYCIN LACTOBIONATE is erythromycin lactobionate. There are one hundred and one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the erythromycin lactobionate profile page.

US Patents and Regulatory Information for ERYTHROMYCIN LACTOBIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062604-002 Nov 24, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062993-001 May 9, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abraxis Pharm ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062604-001 Nov 24, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062993-002 May 9, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Parenteral ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 063253-001 Jul 30, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Parenteral ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 063253-002 Jul 30, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Merck
AstraZeneca
QuintilesIMS
Daiichi Sankyo
Cerilliant
Mallinckrodt
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot